23andMe Launches Month-Long Initiative to Amplify ARRAY’s “Seat16” Program for Acclaimed Film ORIGIN by Ava DuVernay
SUNNYVALE, Calif., Jan. 30, 2024 (GLOBE NEWSWIRE) — 23andMe Holding Co. (Nasdaq:ME) (23andMe), a leading genetic health and biopharmaceutical company, announced a month-long initiative to amplify Ava DuVernay’s new film ORIGIN and the film’s groundbreaking Seat16 program. Seat16 allows anyone to gift $16 or more to purchase an ORIGIN movie ticket for a young person who might not otherwise be able to purchase a ticket to the film. For 23 days, 23andMe will donate 100 seats daily to support the program.
Related news for (ME)
- Patriot Battery Metals Announces Proposed Name Change to PMET RESOURCES
- VerifyMe Provides Services Update
- Late-Day Lightning: Biotech Breakouts SaaS Surge & Biotech Breakouts
- Vimeo Enters into Definitive Agreement to Be Acquired by Bending Spoons for $1.38 Billion
- 24/7 Market News Snapshot 10 September, 2025 – Vimeo, Inc. Common Stock (NASDAQ:VMEO)